首页> 外文期刊>Virology Journal >Induction of neutralizing antibodies specific for the envelope proteins of the koala retrovirus by immunization with recombinant proteins or with DNA
【24h】

Induction of neutralizing antibodies specific for the envelope proteins of the koala retrovirus by immunization with recombinant proteins or with DNA

机译:通过重组蛋白或DNA的免疫诱导对考拉逆转录病毒包膜蛋白具有特异性的中和抗体

获取原文
           

摘要

Background The koala retrovirus (KoRV) is the result of a transspecies transmission of a gammaretrovirus with fatal consequences for the new host. Like many retroviruses, KoRV induces lymphoma, leukemia and an immunodeficiency that is associated with opportunistic infections in the virus-infected animals. We recently reported the induction of neutralizing antibodies by immunization with the recombinant ectodomain of the transmembrane envelope protein p15E of KoRV. Since the neutralization titers of the p15E-specific sera were only moderate, we investigated the use of the surface envelope protein gp70 to induce neutralizing antibodies. Findings We immunized rats and goats with the recombinant gp70 protein of the KoRV, an unglycosylated protein of 52kD (rgp70/p52) or with the corresponding DNA. In parallel we immunized with recombinant rp15E or with a combination of rp15E and rgp70/p52. In all cases binding and neutralizing antibodies were induced. The gp70-specific sera had titers of neutralizing antibodies that were 15-fold higher than the p15E-specific sera. Combining rp15E and rgp70/p52 did not significantly increase neutralizing titers compared to rgp70/p52 alone. High titers of neutralizing antibodies specific for gp70 were also induced by immunization with DNA. Since KoRV and PERV are closely related, we investigated cross-neutralization of the antisera. The antisera against p15E and gp70 of PERV and KoRV inhibited infection by both viruses. Conclusion The envelope proteins of the KoRV may therefore form the basis of an effective preventive vaccine to protect uninfected koalas from infection and possibly an immunotherapeutic treatment for those already infected.
机译:背景考拉逆转录病毒(KoRV)是伽马逆转录病毒跨物种传播的结果,会对新宿主造成致命后果。像许多逆转录病毒一样,KoRV诱发淋巴瘤,白血病和与病毒感染动物中机会性感染有关的免疫缺陷。我们最近报道了通过用KoRV跨膜包膜蛋白p15E的重组胞外域免疫来诱导中和抗体。由于p15E特异性血清的中和滴度只有中等水平,因此我们研究了使用表面包膜蛋白gp70诱导中和抗体。结果我们用KoRV的重组gp70蛋白,52kD的未糖基化蛋白(rgp70 / p52)或相应的DNA免疫了大鼠和山羊。平行地,我们用重组rp15E或rp15E和rgp70 / p52的组合免疫。在所有情况下,诱导结合抗体和中和抗体。 gp70特异性血清的中和抗体效价比p15E特异性血清高15倍。与单独使用rgp70 / p52相比,将rp15E和rgp70 / p52结合使用不会显着增加中和效价。通过用DNA免疫还可以诱导出高滴度的gp70特异的中和抗体。由于KoRV和PERV密切相关,因此我们研究了抗血清的交叉中和作用。针对PERV和KoRV的p15E和gp70的抗血清可抑制两种病毒的感染。结论KoRV的包膜蛋白可能因此成为有效的预防性疫苗的基础,以保护未感染的考拉免受感染,并可能对已经感染的考拉进行免疫治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号